Strontium ranelate returns to the UK as an osteoporosis drug treatment
People with osteoporosis in the UK now have access to the osteoporosis medication strontium ranelate, which returned to the UK market today.
NHS releases new Long Term Plan
The NHS has released its new 10-year plan, outlining plans to future-proof the health service and improve patient care over the coming decade.
Strontium ranelate returns to the UK market
The osteoporosis medication strontium ranelate will once again be available in the UK from January 2019.
Audit of fracture liaison services finds improvements in patient care
Improvements have been made in the standard of care for people with broken bones caused by osteoporosis, a new report by the Royal College of Physicians has found.
Charity's new expert consensus statement on physical activity and exercise for osteoporosis launched
The National Osteoporosis Society has worked with leading clinical experts to develop ‘Strong, Steady & Straight: an expert consensus statement on physical activity and exercise for osteoporosis’, which launched today at its national biennial conference, Osteoporosis 2018.